Immune thrombocytopenia (ITP, formerly idiopathic thrombocytopenic purpura) – platelet deficiency with increased bleeding tendency "Support" Homeopathy according to Dr. Banerji

Dr. Banerji Protocols

Immune thrombocytopenia (ITP, formerly idiopathic thrombocytopenic purpura) – deficiency of platelets with increased bleeding tendency

Immune thrombocytopenia (ITP), formerly known as idiopathic thrombocytopenic purpura, is an acquired disorder in which the number of platelets in the blood is reduced.

Platelets are essential for blood clotting. In severe thrombocytopenia, the tendency to bleed may therefore be increased.

Today, the term immune thrombocytopenia is predominantly used, as it is known that immunological mechanisms play a central role in the disease.

What happens in ITP?

In ITP, the immune system targets the body's own platelets or structures involved in their formation.

This can lead to:

• accelerated platelet destruction

• reduced platelet production in the bone marrow

• overall significantly reduced platelet count

.

Breakdown occurs, among other places, in the spleen and other areas of the mononuclear phagocyte system.

Typical symptoms

The symptoms depend, among other things, on the platelet count and individual bleeding tendency.

Possible symptoms include:

• small pinpoint skin hemorrhages (petechiae)

• larger skin hemorrhages (purpura)

• unusually many bruises

• nosebleeds

• gum bleeding

• prolonged bleeding after minor injuries

• heavy menstrual bleeding

• mucosal bleeding

Some people have only minor or no symptoms despite a significantly reduced platelet count.

Petechiae and Purpura

Petechiae are small, pinpoint hemorrhages into the skin. They typically do not blanch when pressed.

Larger, flat skin hemorrhages are called purpura or ecchymoses.

Such changes can occur in ITP, but are not specific to this disease. Other clotting disorders, infections, medications, or hematological diseases can also cause similar skin changes.

Acute and chronic ITP

In children, ITP often occurs after an infection and can spontaneously resolve within a few months.

In adults, a more prolonged or chronic course is more common.

Depending on the duration, a distinction is made between newly diagnosed, persistent, and chronic ITP.

Primary and secondary ITP

In primary ITP, there is no other clearly underlying disease.

A secondary immune thrombocytopenia can occur in conjunction with other diseases or factors, such as:

• autoimmune diseases such as systemic lupus erythematosus

• certain viral infections

• HIV

• Hepatitis C

• certain lymphatic or hematological diseases

• some medications

Therefore, diagnostics also include the search for possible secondary causes.

Thrombocytopenia does not automatically mean ITP

A reduced platelet count can have numerous other causes.

These include, among others:

• medications

• severe infections

• liver diseases

• enlarged spleen

• bone marrow diseases

• vitamin deficiencies

• thrombotic thrombocytopenic purpura (TTP)

• disseminated intravascular coagulation (DIC)

• pregnancy-associated thrombocytopenia

These diseases may sometimes require completely different and urgent treatment.

Diagnosis

The diagnosis of ITP is essentially a diagnosis of exclusion.

Investigations may include:

• complete blood count

• repeated platelet count determination

• examination of the blood smear

• coagulation parameters

• liver and kidney values

• testing for certain infections

• clarification of possible autoimmune diseases

• review of medications taken

In selected cases, further hematological examinations, including a bone marrow examination, may be necessary.

Pseudothrombocytopenia

In the case of an unexpectedly low platelet count, so-called pseudothrombocytopenia should also be ruled out.

In this condition, platelets clump together in the blood sample, causing the laboratory device to falsely report a low platelet count.

Treatment

Not every patient with ITP immediately requires drug therapy.

The decision depends not solely on a single platelet count, but particularly on:

• bleeding signs

• platelet count level

• age

• comorbidities

• medication intake

• individual bleeding risks

• planned surgeries or procedures

In cases of low bleeding tendency, controlled observation may be sufficient in certain situations.

Corticosteroids and Immunoglobulins

If treatment is required, corticosteroids in particular may be used.

In cases of increased bleeding risk or when a rapid increase in platelets is necessary, intravenous immunoglobulins (IVIG) may be used.

The effect can be rapid but is often temporary.

Further treatment options

For persistent or chronic ITP, further therapies are available, such as:

• thrombopoietin receptor agonists

• rituximab

• further immunomodulatory or immunosuppressive therapies

• splenectomy in selected cases

The choice depends on the individual course of the disease and the benefit-risk profile.

Platelet transfusion

Platelet transfusion is not routinely performed in ITP solely due to a low platelet count.

However, in cases of life-threatening or severe acute bleeding, platelets may be necessary along with other specific measures.

Medications and bleeding risk

In severe thrombocytopenia, medications that affect platelet function or blood clotting can further increase the risk of bleeding.

These include, for example:

• acetylsalicylic acid (ASA)

• certain non-steroidal anti-inflammatory drugs

• anticoagulants

Whether such medications should be discontinued, avoided, or continued must be decided individually by a medical professional. Prescribed anticoagulants should not be stopped independently.

Risk of severe bleeding

Most ITP patients do not develop life-threatening bleeding. However, the risk increases with very severe thrombocytopenia.

Particularly feared are:

• severe gastrointestinal bleeding

• pronounced mucosal bleeding

• intracranial hemorrhages

Cerebral hemorrhage is rare but represents a life-threatening complication.

ITP in pregnancy

Immune thrombocytopenia can also exist during pregnancy or be diagnosed for the first time.

It must be differentiated from other causes of thrombocytopenia in pregnancy.

Management is carried out in close cooperation between obstetrics and hematology, depending on the severity.

Homeopathy according to Dr. Banerji

In homeopathy according to Dr. Banerji, for bleeding tendency, purpura, and various hematological complaints, specific homeopathic remedies and potencies are used according to the Banerji protocols.

A reliable normalization of the platelet count, treatment of the underlying immune thrombocytopenia, or prevention of severe bleeding through homeopathic remedies is not scientifically proven.

Necessary hematological monitoring and treatment with corticosteroids, immunoglobulins, or other specific therapies must not be replaced or delayed by homeopathic remedies.

Important note

In cases of severe or uncontrollable bleeding, blood in vomit or stool, pronounced mucosal bleeding, sudden very severe headaches, visual disturbances, speech disorders, paralysis, altered consciousness, or after a relevant head injury with severe thrombocytopenia, immediate medical evaluation is required.

A newly detected significant thrombocytopenia should always be medically or hematologically clarified, as other treatable causes besides ITP may be present.

The information on this page is for general information purposes only and does not replace medical advice, diagnosis, or treatment.

Ingredients: Hamamelis virg., Arnica montana, Kalium mur., Ferrum phosph., Crotalus horridus, Medorrhinum